Inify Laboratories
Fredrik Palm is currently working as the Chief Executive Officer at Inify Laboratories. Prior to their current role, Fredrik has held various leadership positions in companies such as ContextVision AB, Bactiguard AB, Perimed AB, and Waters. With a background in engineering and a strong focus on sales and marketing, Fredrik has gained extensive experience and global responsibility in these areas throughout their career. Fredrik has also completed executive education programs at Stockholm School of Economics, IHM Business School, FEI Företagsekonomiska Institutet, and Stockholm Institute of Technology.
Inify Laboratories
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system. The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.